摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

tert-butyl (4S,4aS,8aR)-4-(4-(4-nitrophenyl)piperazine-1-carbonyl)octahydroisoquinoline-2(1H)-carboxylate | 1221508-69-5

中文名称
——
中文别名
——
英文名称
tert-butyl (4S,4aS,8aR)-4-(4-(4-nitrophenyl)piperazine-1-carbonyl)octahydroisoquinoline-2(1H)-carboxylate
英文别名
——
tert-butyl (4S,4aS,8aR)-4-(4-(4-nitrophenyl)piperazine-1-carbonyl)octahydroisoquinoline-2(1H)-carboxylate化学式
CAS
1221508-69-5
化学式
C25H36N4O5
mdl
——
分子量
472.585
InChiKey
BJDFTGWLUHPDDW-YUXAGFNASA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.92
  • 重原子数:
    34.0
  • 可旋转键数:
    3.0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.68
  • 拓扑面积:
    96.23
  • 氢给体数:
    0.0
  • 氢受体数:
    6.0

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    tert-butyl (4S,4aS,8aR)-4-(4-(4-nitrophenyl)piperazine-1-carbonyl)octahydroisoquinoline-2(1H)-carboxylate三氟乙酸 作用下, 以 二氯甲烷 为溶剂, 以82%的产率得到((4S,4aS,8aR)-decahydroisoquinolin-4-yl)(4-(4-nitrophenyl)piperazin-1-yl)methanone
    参考文献:
    名称:
    Decahydroisoquinoline derivatives as novel non-peptidic, potent and subtype-selective somatostatin sst3 receptor antagonists
    摘要:
    Starting from non-peptidic sst(1)-selective somatostatin receptor antagonists, first compounds with mixed sst(1)/sst(3) affinity were identified by directed structural modifications. Systematic optimization of these initial leads afforded novel, enantiomerically pure, highly potent and sst(3)-subtype selective somatostatin antagonists based on a (4S,4aS,8aR)-decahydroisoquinoline-4-carboxylic acid core moiety. These compounds can efficiently be synthesized and show promising PK properties in rodents. (C) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2010.01.063
  • 作为产物:
    参考文献:
    名称:
    Decahydroisoquinoline derivatives as novel non-peptidic, potent and subtype-selective somatostatin sst3 receptor antagonists
    摘要:
    Starting from non-peptidic sst(1)-selective somatostatin receptor antagonists, first compounds with mixed sst(1)/sst(3) affinity were identified by directed structural modifications. Systematic optimization of these initial leads afforded novel, enantiomerically pure, highly potent and sst(3)-subtype selective somatostatin antagonists based on a (4S,4aS,8aR)-decahydroisoquinoline-4-carboxylic acid core moiety. These compounds can efficiently be synthesized and show promising PK properties in rodents. (C) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2010.01.063
点击查看最新优质反应信息